MCP-1 targeting i-body (AdAlta)

N/A

Report date: 2025/03/20 15:42:47

Base Information

Drug NameMCP-1 targeting i-body (AdAlta)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionC-C motif chemokine 2 modulators
TargetsC-C motif chemokine 2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdAlta Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdAlta Pty Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A